Miihir Chemosol Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
- Revenue Growth 154.64%
- Profit Growth 556.78%
- Ebitda 261.82%
- Net Worth 251.12%
- Total Assets 90.25%
About Miihir Chemosol
Miihir Chemosol Private Limited (MCPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 2019 (Five years and five months 17 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Pratibha Suki and Laxman Suki serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24299MH2019PTC329957
-
Company No.
329957
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Miihir Chemosol?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratibha Suki
|
Additional Director | 01-Sep-2023 | Current |
|
Laxman Suki
|
Director | 29-Aug-2019 | Current |
Financial Performance of Miihir Chemosol.
Miihir Chemosol Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 154.64% increase. The company also saw a substantial improvement in profitability, with a 556.78% increase in profit. The company's net worth Soared by an impressive increase of 251.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Miihir Chemosol?
In 2023, Miihir Chemosol had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Indian Overseas Bank | ₹2.00 Cr | Open |
How Many Employees Work at Miihir Chemosol?
Miihir Chemosol has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Miihir Chemosol, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miihir Chemosol's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
